Sepsis Risk Study in Chinese ICU Patients
Part of Infections clinical trials.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older and in the ICU.
- If you have sepsis, it must have started within 72 hours of being in the ICU.
- If you don't have sepsis, you must be in the ICU for at least 24 hours without signs of infection.
- You cannot have end-stage organ failure (like severe kidney, liver, or heart disease) or cancer that has spread.
- You must not have a weak immune system (from autoimmune disease or certain medicines in the last 3 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple blood test can help doctors find out if ICU patients with infections are likely to develop sepsis within the next 48 hours. If you join, the researchers will measure a protein in your blood and follow you to see if you get sepsis.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This study collects information from adult patients hospitalized with sepsis to better understand how sepsis affects people in China. By joining, you'll help researchers learn more about this condition to improve future care.
This study looks at the bacteria in the gut of patients with sepsis in the ICU. It aims to understand how these bacteria change during critical illness, which could lead to better treatments.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
This study looks at how your immune cells respond during a severe infection in the ICU. It aims to better predict how the infection will progress and help tailor treatment.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.